MedPath

Study the effect of syrup Rubyclin and Dadruvidravan ointment in skin disease

Phase 2
Conditions
Health Condition 1: L089- Local infection of the skin and subcutaneous tissue, unspecified
Registration Number
CTRI/2020/09/027972
Lead Sponsor
Ayurved Mahavidyalaya Nashik
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients with classical signs and symptoms of the Dadru kushta like kandu (Itching) Raga (Redness) Pidika (Papules)

Not suffering from any other chronic infectious disease including HIV

Patient willing to participate in study and those who give written consent

Exclusion Criteria

The pregnant and lactating mother

Patient with uncontrolled systemic disorders like DM Hypertension Cardiac disorder psoriasis Leprosy Tuberculosis Malignancy etc

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reduction in sign symptoms of Dadru <br/ ><br>Reduction in affected areaTimepoint: 30 days
Secondary Outcome Measures
NameTimeMethod
ormalization of skinTimepoint: 30 days
© Copyright 2025. All Rights Reserved by MedPath